Bryant E. Fong's most recent trade in Adma Biologics Inc was a trade of 37,541 Stock Option (right to buy) done . Disclosure was reported to the exchange on Feb. 26, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Adma Biologics Inc | Bryant E. Fong | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2024 | 37,541 | 37,541 | - | - | Stock Option (right to buy) | |
| Adma Biologics Inc | Bryant Fong E. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2024 | 24,040 | 83,941 (0%) | 0% | 0 | Common Stock | |
| Adma Biologics Inc | Bryant E. Fong | Director | Sale of securities on an exchange or to another person at price $ 3.87 per share. | 22 Aug 2023 | 1,433,304 | 0 (0%) | 1% | 3.9 | 5,544,737 | Common Stock |
| Adma Biologics Inc | Bryant E. Fong | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 51,630 | 51,630 | - | - | Employee Stock Option (right to buy) | |
| Adma Biologics Inc | Bryant E. Fong | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 25,815 | 59,901 (0%) | 0% | 0 | Common Stock | |
| Adma Biologics Inc | Bryant E. Fong | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2022 | 53,172 | 53,172 | - | - | Employee Stock Option (right to buy) | |
| Adma Biologics Inc | Bryant E. Fong | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2022 | 26,586 | 34,086 (0%) | 0% | 0 | Common Stock | |
| Adma Biologics Inc | Bryant E. Fong | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 55,000 | 55,000 | - | - | Stock Option (right to buy) |